Encompass Health Corp (EHC) stock
EHCNYSEServices-HospitalsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 16/3010% above fair value
$134.93−2.95 (-2.14%)
Close on Nov 18, 2026Market cap $13.31BP/E 22.0Yield 0.53%
Encompass Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Encompass Health's revenue for the twelve months ending Jun 30, 2026 was $6.21B, up 9.5% year over year. For fiscal 2025 it was $5.94B, up 10.5% from the year before. The highest annual figure on record is $5.94B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.94B | +10.5% |
| FY2024 | Dec 31, 2024 | $5.37B | +11.9% |
| FY2023 | Dec 31, 2023 | $4.80B | +10.4% |
| FY2022 | Dec 31, 2022 | $4.35B | +8.3% |
| FY2021 | Dec 31, 2021 | $4.01B | +12.6% |
| FY2020 | Dec 31, 2020 | $3.57B | -22.6% |
| FY2019 | Dec 31, 2019 | $4.61B | +7.7% |
| FY2018 | Dec 31, 2018 | $4.28B | +9.3% |
| FY2017 | Dec 31, 2017 | $3.91B | +7.4% |
| FY2016 | Dec 31, 2016 | $3.64B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.60B | +9.6% |
| Q1 FY2026 | Mar 31, 2026 | $1.59B | +9.0% |
| Q4 FY2025 | Dec 31, 2025 | $1.54B | +9.9% |
| Q3 FY2025 | Sep 30, 2025 | $1.48B | +9.4% |
| Q2 FY2025 | Jun 30, 2025 | $1.46B | +12.0% |
| Q1 FY2025 | Mar 31, 2025 | $1.46B | +10.6% |
| Q4 FY2024 | Dec 31, 2024 | $1.41B | +12.7% |
| Q3 FY2024 | Sep 30, 2024 | $1.35B | +11.9% |
| Q2 FY2024 | Jun 30, 2024 | $1.30B | +9.6% |
| Q1 FY2024 | Mar 31, 2024 | $1.32B | +13.4% |
| Q4 FY2023 | Dec 31, 2023 | $1.25B | +9.6% |
| Q3 FY2023 | Sep 30, 2023 | $1.21B | +10.8% |
| Q2 FY2023 | Jun 30, 2023 | $1.19B | +11.7% |
| Q1 FY2023 | Mar 31, 2023 | $1.16B | +9.5% |
| Q4 FY2022 | Dec 31, 2022 | $1.14B | +9.1% |
| Q3 FY2022 | Sep 30, 2022 | $1.09B | +7.8% |
| Q2 FY2022 | Jun 30, 2022 | $1.06B | +6.1% |
| Q1 FY2022 | Mar 31, 2022 | $1.06B | +10.4% |
| Q4 FY2021 | Dec 31, 2021 | $1.04B | -14.2% |
| Q3 FY2021 | Sep 30, 2021 | $1.01B | -13.9% |
| Q2 FY2021 | Jun 30, 2021 | $1.00B | -6.7% |
| Q1 FY2021 | Mar 31, 2021 | $959.90M | -18.8% |
| Q4 FY2020 | Dec 31, 2020 | $1.21B | +2.5% |
| Q3 FY2020 | Sep 30, 2020 | $1.17B | +1.1% |
| Q2 FY2020 | Jun 30, 2020 | $1.07B | -5.4% |
| Q1 FY2020 | Mar 31, 2020 | $1.18B | +5.2% |
| Q4 FY2019 | Dec 31, 2019 | $1.18B | +8.1% |
| Q3 FY2019 | Sep 30, 2019 | $1.16B | +8.8% |
| Q2 FY2019 | Jun 30, 2019 | $1.14B | +6.3% |
| Q1 FY2019 | Mar 31, 2019 | $1.12B | +7.5% |
| Q4 FY2018 | Dec 31, 2018 | $1.10B | +8.6% |
| Q3 FY2018 | Sep 30, 2018 | $1.07B | +8.8% |
| Q2 FY2018 | Jun 30, 2018 | $1.07B | +10.5% |
| Q1 FY2018 | Mar 31, 2018 | $1.05B | +9.3% |
| Q4 FY2017 | Dec 31, 2017 | $1.01B | – |
| Q3 FY2017 | Sep 30, 2017 | $981.60M | – |
| Q2 FY2017 | Jun 30, 2017 | $966.40M | – |
| Q1 FY2017 | Mar 31, 2017 | $957.10M | – |
See a number that looks wrong?